Company

Indivumed

Biotechnology Research Hamburg, De 95 employees

Employees: 95
Contacts: 3
Emails: 3

www.indivumed.com LinkedIn

Indivumed Overview

Headquarters: Hamburg, De
Website: www.indivumed.com
Industry: Biotechnology Research
Employees: 95
Founded: 2002
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biobanking Tumor Profiling Target Identifcation and Validation Target Discovery Multi-Omics Drug Development Precision Oncology Biomathematics and AI

About Indivumed

Indivumed is a biotech company focused on precision oncology. With our unique approach to collecting tissue and data of unmatched quality and variety, we have unlocked a deep understanding of the molecular reality of cancer. This way, we are able to discover novel therapeutic targets that would otherwise be undetectable. Through in-house efforts we can progress small and large molecules toward IND and beyond. With more than 20 years of innovation, we remain true to our vision: a world where precision oncology offers a cure for every cancer patient. To learn more about our mission, visit www.indivumed.com. Imprint: https://www.indivumed.com/imprint Privacy Policy Social Media: https://www.indivumed.com/data-protection-policy-social-media/

Indivumed Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Indivumed Org Chart

Sample employees and titles

Name	Title	Location	Contact
Giorgio Modesti	Director of Operations, Southern Europe at Indivumed Therapeutics	Rome, Latium, Italy	Email
Nils John Schumacher	COO Indivumed Therapeutics	Hamburg, Germany	Email
Peter Behner	Member of the Supervisory Board at Mink Therapeutics		View
Matthias Evers	Biopharma Exec, Advisor & Investor - Building at the Intersection of Human Data, Discovery & Healthspan - Let’s Create What’s Next	Hamburg, Germany	Email